Cyclosporine A (CsA) has represented a fundamental therapeutic weapon in immunosupression for the past three decades. However, its clinical use is not devoid of side effects, among which hypertension and vascular injury represent a major drawback. Endothelial cells are able to generate reactive oxygen and nitrogen species upon exposure to CsA, including formation of peroxynitrite. This may result in endothelial cell toxicity and increased tyrosine nitration. We have now studied the subcellular origin of superoxide formation in endothelial cells treated with CsA and the biochemical consequences for the function of mitochondrial enzymes.
Introduction
Cyclosporine A (CsA) has been for many years an essential therapeutic tool in the fields of solid organ transplantation and autoimmune diseases. Its mechanism of action, based on the inhibition of the phosphatase calcineurin upon CsA binding to cyclophilin proteins, is now well known and shared in part by other immunosuppressors such as Tacrolimus. 1, 2 However, serious side effects associated to its clinical use still promote significant morbidity and dictate changes in therapeutic strategies. Among them, vascular injury is an important one as it is reflected in post-transplant hypertension, accelerated atherosclerosis, and occasionally in the appearance of thrombotic microangiopathy. 3 Several reports point to the importance of oxidative stress as a pathogenetic mechanism responsible for this undesired damage (see 4 for review). Oxidative stress is the result of the action of reactive oxygen species (ROS) 5 on different molecular targets and it is now accepted that the latter do not only participate in pathophysiological responses but are also important signals for some homeostatic cellular functions. 6 In addition, reactive nitrogen species (RNS) such as nitric oxide or peroxynitrite may have a dual physiological and pathophysiological role, and hence the term nitroxidative stress has been coined. 7, 8 Vascular injury associated to the clinical use of CsA is pathogenetically related to endothelial dysfunction 9 promoted by increased nitroxidative stress. 10 -13 Cellular sources generating ROS and RNS in endothelial cells are multiple, including several enzymatic systems and the mitochondrial electron transport chain. The contribution of mitochondria to ROS generation has received increasing attention in recent years and this is especially noticeable in endothelial cells and vascular pathophysiology. 14 In previous work from our laboratory, we found that CsA promotes the generation of superoxide and peroxynitrite in the vascular endothelium and that this effect is associated with increased protein tyrosine nitration which may be prevented by the concomitant use of antioxidant agents. 15 Among these proteins, manganese superoxide dismutase (MnSOD) appeared as a strong candidate, given the fact that tyrosine nitration specifically inactivates its catalytic activity 16 -18 by a Mn-catalyzed nitration of tyrosine 34 (Tyr34). 19 Nevertheless, several important questions remain to be answered including: (i) the subcellular topology of ROS generation mediated by CsA, (ii) the functional consequences of CsA treatment on the activity of MnSOD in endothelial cells, and (iii) the identification of specific tyrosine residues which undergo nitration induced by CsA. In this manuscript, we provide data demonstrating the mitochondrial generation of CsA induced superoxide in vascular endothelial cells, the inhibition of MnSOD activity by CsA and the specific nitration of Tyr34 promoted by CsA in this same enzyme.
Methods
An expanded version of Material and Methods can be found as Supplementary material online.
Cells
Bovine aortic endothelial cells (BAEC) were obtained from aortas donated by a local slaughterhouse and cultured as described. 20 Mouse lung endothelial cells (MLEC) were isolated as described. 21 All protocols used conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23).
Flow cytometry
An EPICS XL analyser was used to quantitate fluorescence at the singlecell level. Data are expressed as percentage of signal related to the control.
MitoSOX-Red fluorescence and confocal microscopy
Images were collected with a Leica TCS SP2 AOBS confocal microscope (Mannheim, Germany).
Electron spin resonance experiments
Electron spin resonance (ESR) signals were detected with a Miniscope MS 200 Magnetech GmbH.
O 2 consumption
Mitochondrial oxygen consumption was measured at 378C using a Clarktype oxygen electrode (Hansatech Instruments, King's Lynn, England).
Aconitase activity
Aconitase activity in the mitochondrial and cytosolic fractions was determined spectrophotometrically using the coupled assay with porcine heart isocitrate dehydrogenase, as described. 22 
MnSOD activity
MnSOD activity was determined in cellular lysates by measuring the inhibition of superoxide-dependent cytochrome c reduction generated by xanthine oxidase/xanthine in the presence of 3 mM potassium cyanide. 23 
Western blot analysis
Western blot analysis was performed as described. 15 
MnSOD nitration
For recombinant human MnSOD nitration experiments, the protein was incubated with conditioned media from BAEC treated with CsA (10 mM, 2 h), its vehicle or nitrating buffer 18 and then processed as described. 15 
Mass spectrometry
MS analysis of peptides was performed by using a Surveyor high performance liquid chromatography (HPLC) system coupled to an LTQ linear ion trap mass spectrometer (ThermoScientific, San Jose, CA, USA) as described. 24 2.11 Nitric oxide determination † NO release was monitorized using an † NO electrode (ISO-NOP; World Precision Instruments, Stevenage, Herts, UK).
Statistics
Unless otherwise specified, data are expressed as means + SEM with the number (n) of experiments indicated. Statistical analysis was performed by unpaired Student's t-test, or non-parametric tests as appropriate.
Results
3.1 Detection of mitochondrial-derived superoxide radical in endothelial cells exposed to CsA ESR is considered a highly specific method for the detection of superoxide. Reaction of superoxide and hydoxyl radicals with the spin trap 5,5 dimethyl-1-pyrroline N-oxide (DMPO) yield the DMPO-OOH adduct (t 1/2 , 1 min) that rapidly decays in the cellular medium to the more stable adduct DMPO-OH. As shown in Figure 1A , when BAEC were incubated with CsA (10 mM, 2 h), an ESR signal with the characteristic spectral properties of DMPO-OH adduct was observed (1:2:2:1 pattern and a N ¼ a H ¼ 14.9 G), and the signal was Endothelial nitration of Tyr34 MnSOD by cyclosporine A significantly abrogated in the presence of the superoxide scavenger Tiron (1 mM), 25 strongly suggesting that superoxide radical is being formed after exposure of BAEC to CsA. The NADPH oxidase inhibitor, apocynin, was unable to quench the CsA induced ESR signal ( Figure 1A ). An identical signal was obtained when BAEC were incubated with the redox cycling agent 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) (25 mM), a known intracellular superoxide generator (see Supplementary material online, Figure S1 ). The fluorescent probe MitoSOX Red 26 was used in order to investigate if mitochondria are the source of CsA-dependent superoxide production. As shown in Figure 1B , treatment of BAEC with both CsA (10 mM, 2 h) and DMNQ (25 mM, 1 h) results in a significant increment of cellular fluorescence, compatible with a mitochondrial localization (see Supplementary material online, Figure S2 ), suggesting that an increase in superoxide and other mitochondrial-derived oxidants are being formed after treatment with CsA. Pre-incubation of cells with the general antioxidant N-acetylcysteine (3 mM) markedly reduced the CsA-dependent MitoSOX-Red fluorescent signal. In order to confirm the important contribution of mitochondrial sources to superoxide generation in endothelial cells, we studied the effect of CsA on BAEC which have been deprived of functional mitochondria (rho0).
As shown in Figure 1C , when cells were incubated with dihydroethidine (DHE) as the fluorescent probe, a significant increase in oxidized DHE fluorescence was detected only in native BAEC and not in rho0 cells upon exposure to CsA, whereas apocynin failed to have any significant effect in both cell types. BAEC treated with DMNQ followed a similar behaviour as those exposed to CsA (see Supplementary material online, Figure S3 ). We take this set of results as strongly supporting that treatment of endothelial cells with CsA increases mitochondrial-derived superoxide and/or oxidant production.
Mitochondrial bioenergetic profile of BAEC treated with CsA
The relationship between cell respiration rate, mitochondria membrane potential (DCm), and ROS production is a complex one. In general, it is accepted that when mitochondria are respiring in state 3, there is a limited generation of superoxide anion. However, when ADP has been phosphorylated and DCm is high, respiratory rates are low and there is an increased superoxide generation by complexes I and III. 27 We sought to study the influence of CsA on several bioenergetic parameters in BAEC. As shown in Figure 2A , CsA caused a significant increase in DCm (measured as the fluorescence intensity of the DiOC 6 f3g probe) that was associated with a decrease in the respiration rate ( Figure 2B ), a slight reduction in intracellular ATP levels (21 + 10% compared with control) and an increase in the production of superoxide as detected with the fluorescent probe DHE ( Figure 2C ). As expected, the protonophore carbonyl cyanide-p-trifluoromethoxyphenyhydrazone (FCCP) lowered DCm, stimulated respiration ( Figure 2A and B) and lowered the mitochondrial production of superoxide (see Supplementary material online, Figure  S4A and B). In an effort to identify the relative contribution of complex I or complex III to CsA-associated superoxide production, we performed experiments in the presence of specific electron transport inhibitors for these two complexes. The addition of different respiratory chain inhibitors (rotenone, myxothiazol, or antimycin A) lead to an increase in superoxide production. The addition of CsA resulted in a further increment in superoxide levels when rotenone or antimycin A were present but not when combined with myxothiazol ( Figure 2C -E). In order to exclude a direct effect of CsA on complex III, we determined its activity in the presence and absence of CsA and we found no significant differences (data not shown).
Functional significance of CsA induced ROS and RNS generation: inhibition of mitochondrial-related enzymatic activities
Previous reported work from our laboratory showed that CsA promotes the generation of peroxynitrite in endothelial cells by favouring spatio-temporal conditions of interaction between superoxide and † NO 12, 28 to yield the strong oxidant peroxynitrite. Intracellular peroxynitrite formation has consequences for endothelial viability, in general promoting oxidation and nitration of cellular targets. Inhibition of aconitase activity (an enzyme present in both mitochondrial and cytosolic compartment) has been widely used as a sensitivity assay for measuring superoxide cellular-compartment levels. 22, 29 Other species such as peroxynitrite or carbonate radical are able to react with and inactivate aconitase, but their production is also a consequence of an increase in superoxide steady-state level. In addition, the mitochondrial enzyme MnSOD becomes inactivated upon nitration. Taking into account these considerations, we were now interested in identifying the functional relevance of CsA treatment on the activities of these mitochondrial enzymes. Figure 3A shows that both the mitochondrial superoxide generator DMNQ and CsA significantly reduced mitochondrial aconitase and MnSOD activities after short-term exposure to CsA. The effect on MnSOD activity was also documented after 24 h of CsA treatment ( Figure 3B ). The antioxidant Tiron and the tyrosine nitration inhibitor uric acid 30 inhibited or partially prevented the effect of CsA on MnSOD activity, ( Figure 3C and D, respectively) . A similar preventive effect of Tiron was observed on aconitase activity (n ¼ 2 by duplicate, data not shown). Aconitase activity was also reduced in cytosolic fractions (data not shown) even when no significant contamination of mitochondria in the cytosolic fractions was detected, as determined by western blot against MnSOD (see Supplementary material online, Figure S5 ).
To prove that the nitration induced by CsA was NOS dependent and that NOS inhibition prevented CsA induced enzymatic inactivation, we performed two types of experiments. First, we studied tyrosine nitration in MLEC arising from both wild-type and endothelial nitric oxide synthase (eNOS) deficient animals. CsA induced tyrosine nitration only in wild-type MLEC as opposed to the peroxynitrite exogenous generator SIN-1 (1,3-morpholino sydnonimine), which also had an effect in MLEC from eNOS-deficient animals ( Figure 4A ). The nitration pattern correlated well with the levels of nitrite (NO 2 2 ) in the extracellular medium, as it was determined using a selective NO electrode ( Figure 4B ). In addition, the NOS inhibitor 2-amino-4-methylpyridine significantly abrogated the effect of CsA on MnSOD activity ( Figure 4C ). These data imply that the generation of superoxide and peroxynitrite by CsA has important functional consequences for the activities of mitochondrial aconitase and MnSOD, both enzymes with a mitochondrial localization. In addition, CsA induced an increase in peroxynitrite generation (as determined by DHR123 flow cytometry experiments) which was only present in wild-type MLEC ( Figure 4D ).
Identification of Tyr34 as the nitrated residue of MnSOD in endothelial cells treated with CsA
Tyr34 has been identified as a critical target for the in vitro nitration and inactivation of MnSOD with functional consequences also in vivo. 31, 32 Thus, it was important to find out if treatment of endothelial cells with CsA could specifically affect this residue. We first set up the conditions for characterizing Tyr34 nitration by mass spectrometry in a preparation of rHuMnSOD exposed to a nitrating buffer. 18 This was accomplished by selected MS/MS ion monitoring (SMIM) using a HPLC-linear ion trap mass spectrometer. 24, 33, 34 The detector was programmed to perform multiple fragmentations of the ions corresponding to the non-modified and Tyr-nitrated forms of the tryptic peptide HHAAY 34 VNNLNVTEEK from MnSOD. By monitoring the fragmentation of the precursor ions and the subfragmentation of one of the most intense fragments, we could demonstrate the nitration at Tyr34 (data not shown). Once the conditions for specifically detecting Tyr34 nitration by SMIM were optimized, we applied the technique to the analysis of rHuMnSOD incubated in the presence of conditioned medium of cells exposed to CsA. The fragmentation patterns and the presence of specific fragments for the non-modified and nitro-Tyr forms of the peptide demonstrated that incubation of the recombinant protein with the conditioned medium produced nitration at the Tyr34 residue of MnSOD (see Supplementary material online, Figure S6 ). Finally, the same approach was followed to analyse this modification in endothelial cells treated with CsA. For this purpose, whole protein extracts from BAEC infected with adenoviral constructs bearing MnSOD were used to perform the same analysis. These infections did not modify the capacity of CsA to induce protein nitration (see Supplementary material online, Figure S7 ). As shown in Figure 5B , the chromatogram trace of specific fragment ions revealed that the modified peptide was present at a negligible proportion in the extracts from vehicle-treated cells. In clear contrast, when the cells were treated with CsA, the intensity of the non-modified peptide decreased ( Figure 5A ), whereas that of the modified peptide increased ( Figure 5B) . The MS/ MS and MS 3 fragment spectra obtained at the elution times of these peaks demonstrated unequivocally the sequence of the peptide and the presence of a modification by 45 Da in Tyr34 ( Figure 5C and D) , consistent with Tyr-nitration at this site. Altogether, these data provide strong evidence suggesting that CsA is able to promote MnSOD nitration in endothelial cells precisely at the residue which is essential for a correct catalytic activation of the enzyme, hence identifying a specific biochemical target for CsA induced endothelial toxicity.
Discussion
This study provides molecular insight into the mechanism of endothelial toxicity associated to CsA. Data presented here strongly support that superoxide production is mainly of mitochondrial origin and that CsA causes a change in membrane potential that leads to a decrease in the respiratory rate and increased ROS generation. This results in a functional inactivation of the mitochondrial enzymes aconitase and MnSOD. Finally, tyrosine nitration of MnSOD by CsA is assigned to a specific residue (Tyr34) which is essential for its catalytic function on superoxide elimination. The association between CsA treatment and increased oxidative stress has been accepted for several years based not only on experimental data but also on clinical observations. In fact, CsA induced or DMNQ (25 mM, 1 h) and mitochondrial aconitase and MnSOD activities were determined as described in Methods section (n ¼ 4 for each enzyme, # P , 0.05 vs. control; $ P , 0.05 vs. control). (B) BAEC were exposed to CsA (1 mM, 24 h), and MnSOD activity was determined (n ¼ 3, *P , 0.05).
(C) Effect of Tiron on the prevention of CsA-associated inhibition of MnSOD activity. BAEC were exposed to Tiron (1 mM, 30 min pre-incubation), and then treated as described in (A) (n ¼ 3, # P , 0.05 vs. control). (D) Effect of uric acid (160 mM) on the prevention of CsA-associated inhibition of MnSOD activity. BAEC were treated with CsA (10 mM, 2 h) alone or in the presence of uric acid (160 mM), and then MnSOD activity was determined as described in Methods section (n ¼ 3, # P , 0.05 vs. control, $ P , 0.05 vs. treatment with CsA).
Endothelial nitration of Tyr34 MnSOD by cyclosporine A hypertension is related to increased ROS production. 35 We and others have provided evidence for the presence of nitroxidative stress in cells from the vascular wall. 5, 15, 36 Data herein presented demonstrate unequivocally by using ESR and fluorescent probes that endothelial cells generate ROS under exposure to CsA. Although it is possible that hydroxyl radical could account for the characteristic ESR signal, abrogation by Tiron and overwhelming evidence on the production of superoxide by mitochondria make this scenario unlikely. Few studies have addressed the issue of the source of ROS in endothelial cells. This work clearly shows that endothelial mitochondria are potential generators of superoxide anion in the presence of CsA ( Figure 1B) . The general nicotinamide adenine dinucleotide phosphate oxidase inhibitor, apocynin, did not result in an inhibition of superoxide production, thus excluding NADPH oxidase as a fundamental source of CsA induced oxidative stress in BAEC. However, the fact that cytosolic aconitase is also partially inhibited by CsA does not completely exclude the possibility of other superoxide sources aside from mitochondria. Besides, results obtained in cells with the absence of functional mitochondria revealed that these organelles are critical for CsA-associated production of superoxide.
However, other authors have found that other endothelial cell types may behave differently in response to CsA. 37 In addition, uncoupling of eNOS has also been suggested as a mechanism for CsA induced superoxide generation in animal models. 38 In our study, the presence of eNOS was clearly necessary for the generation of peroxynitrite and induction of nitration (Figure 4) , thus suggesting that this mechanism could also be contributing to superoxide generation. The effects of CsA on mitochondrial function need to be interpreted in the context of established actions of this drug on the mitochondrial permeability transition pore (PTP). Among CsA direct actions, binding to cyclophilin D in the mitochondrial matrix leads to the inhibition of the PTP. PTP opens under a variety of conditions related to mitochondrial dysfunction like ROS-induced damage, an elevation of mitochondrial calcium and phosphate, depletion of pyridine nucleotides, or high levels of fatty acids. Prolonged PTP opening leads to matrix swelling and disruption of the outer membrane with the concomitant release of pro-apoptotic factors. The inhibition of PTP opening by CsA can be used to increase the cell viability and prevent, for example, cell death after ischaemia- Figure 4 The eNOS pathway is necessary for CsA-dependent nitration and peroxynitrite formation. (A) MLEC wild-type and knockout (KO) for eNOS were exposed to CsA (10 mM, 2 h) or the generator of peroxynitrite SIN-1 (100 mM, 2 h), and protein lysates were processed as described in Methods section. Control cellular extracts were exogenously treated with the same concentration of SIN-1 for 1 h (extr/SIN-1). Tyrosine nitration was evaluated by immunoblot. (B) NO 2 2 accumulation was determined with a selective NO electrode in supernatants of MLEC exposed to CsA or SIN-1, in the conditions described above (n ¼ 3, # P , 0.05 vs. control). (C) BAEC were treated with CsA (10 mM, 2 h) alone or in the presence of AMPy (100 mM), and then MnSOD activity was determined as described in Methods section (n ¼ 3, indicated with the same nomenclature used previously. 53 Note that fragments of this kind are observed with some frequency upon refragmentation and their formation is thought to arise from cyclation of intense b ions. 53 Spectra correspond to a representative experiment repeated twice.
Endothelial nitration of Tyr34 MnSOD by cyclosporine A reperfusion. 39 However, electrophysiological studies have shown that the PTP can also open transiently (in the millisecond range) and this channel activity is referred to as 'conductance flickerings'. 40 These transient openings are also CsA sensitive and probably related to fluctuations in physiological parameters such as matrix pH or to physiological activities like protein import or fast calcium release. The flickering of the PTP is therefore a physiological event that does not necessarily lead to the dramatic effects due to the permanent opening of the PTP. 41 We have observed a CsA induced increase in
DCm that could be due to the inhibition of the flickering of the pore (Figure 2A) . The observed decrease in respiration ( Figure 2B ) would also be a consequence of the increased efficiency of the oxidative phosphorylation and higher DCm.
The effect of the two modes of PTP opening would have different consequences on the mitochondrial production of superoxide. It has been reported that prolonged opening of the PTP is associated with increased levels of H 2 O 2 in mitochondria due to a specific conformational change in complex I. 42 The loss of cytochrome c, due to the rupture of the outer mitochondrial membrane, has also been considered a cause of both the inhibition of respiration and the concomitant increase in ROS production due to the opening of the PTP. 43, 44 However, recent studies in cardiomyocytes subjected to ischaemiareperfusion have shown that the production of ROS increase when the PTP is inhibited by CsA, 45 in keeping with data presented here.
We believe that the marked increase in DHE fluorescence that we have observed in the presence of CsA is consistent with a possible non-permanent inhibition of the PTP. MnSOD (SOD-2) is a mitochondrial enzyme considered to be essential as a first-line superoxide detoxifier. In the vascular wall, this enzyme has been shown to play a crucial role in vascular protection. 46 MnSOD converts superoxide into hydrogen peroxide plus molecular oxygen. This conversion has several purposes including the protection of † NO and mitochondrial proteins such as aconitase or fumarase from inactivation by superoxide. 46 The Mn atom is essential for redox cycling and the Tyr34 residue lies in close proximity to this atom and hence to the active site. 47 Nitration of this residue was demonstrated more than 10 years ago and it is widely accepted that this modification involves enzymatic inactivation. 8 Moreover, peroxynitrite is the only known biological oxidant competent to inactivate MnSOD enzymatic activity. 47 Several studies have highlighted the pathophysiological importance of MnSOD nitration in a panoply of disease models, including chronic renal allograft rejection, 16 traumatic brain injury, 48 ageing, 49 and angiotensin II-induced hypertension. 50 We now provide evidence for the functional inactivation of MnSOD by CsA together with a repercussion on the function of an exquisitely sensitive enzyme to superoxide, aconitase ( Figure 3) . Also, and for the first time to our knowledge, we show that CsA induced nitration of MnSOD takes place precisely at Tyr34, thus offering a biochemical explanation for MnSOD inactivation ( Figure 5) . Furthermore, the protection from MnSOD inactivation by treatment of the cells with uric acid, a well known anti-nitrating compound via scavenging of peroxynitrite-derived radicals, 51, 52 further supports a direct link between CsA toxicity and mitochondrial nitroxidative stress. Although we attempted to quantitate the amount of nitration of MnSOD, experiments using an antibody specifically directed against nitrated MnSOD (nY-34) 49 were inconclusive (data not shown).
Nitration of Tyr34 in MnSOD can lead to a fully inactivated enzyme; 19 the fact that we only observed about 40% inhibition of MnSOD in the presence of CsA supports that only a fraction of the total MnSOD pool becomes nitrated in the critical tyrosine upon CsA exposure. Indeed, fractional MnSOD nitration/inactivation under cellular conditions will depend on both the overall production of peroxynitrite over the incubation period and the competing reactions with other targets and detoxification systems. Given these considerations, one can conclude that peroxynitrite formation in the system under study was large, as it significantly dropped the activity of MnSOD, typically present at 10-20 mM concentrations in mitochondria. 29 In addition, experiments performed in BAEC infected with adenoviral constructs bearing a MnSOD expression plasmid strongly suggest that CsA induced Tyr34 nitration is operative in endothelial cells. Of interest, the concentrations of CsA used in this study (1 -10 mM) are slightly above the high limit of the therapeutic range of concentrations found in renal transplant patients treated with these agents, and hence expected to be found in the context of vascular toxicity. Thus, it is tempting to speculate that a reduced catalytic activity of endothelial MnSOD would contribute to amplify nitroxidative stress and to promote the self-perpetuation of endothelial damage.
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